Morris Animal Foundation's Golden Retriever Lifetime Study will help identify major nutritional, genetic and environmental risk factors for cancer and other important diseasesin dogs.
Displaying 1 - 7 of 77 Results
Researchers will develop an assay to measure canine thrombopoietin (TPO), a bone marrow growth factor, to improve the diagnosis and treatment of bleeding disorders in dogs with immune platelet defects.
Researchers will identify potential treatment targets for B-cell chronic lymphocytic leukemia in dogs and ways to identify high-risk patients.
Researchers will determine if common heart medications are an effective adjunct therapy for dogs with hemangiosarcoma.
Researchers will explore metabolic drivers of cancer growth and look for new therapy targets for osteosarcoma, the most common type of bone cancer in dogs.
Researchers will evaluate an advanced imaging technique to improve the diagnosis and monitoring of spinal cord lesions associated with canine degenerative myelopathy, a spinal cord disease in dogs.
Researchers will evaluate the effects of additive solutions to improve blood platelet efficacy and storage for life-saving transfusion in dogs.